Search Login Register
mycophenolate mofetil
(Cellcept)
Summary
1276
relevant articles (130 outcomes,
135 trials/studies)
found for this Drug
Description:
mycophenolic acid that is chemically altered by the addition of morpholinoethylester; selective and reversible inhibitor of inosine monophosphate dehydrogenase
Also Known As:
Cellcept; RS 61443; RS-61443; mycophenolate mofetil hydrochloride; mycophenolic acid morpholinoethyl ester
Key Diseases for which mycophenolate mofetil is
Relevant
-
Lupus Nephritis
:
22 outcomes 29 studies in 104 results
-
Proteinuria
:
8 outcomes 7 studies in 38 results
-
Nephrotic Syndrome (Syndrome, Nephrotic)
:
8 outcomes 6 studies in 40 results
-
Graft vs Host Disease (Graft-Versus-Host Disease)
:
8 outcomes 5 studies in 123 results
-
Systemic Lupus Erythematosus (Libman-Sacks Disease)
:
6 outcomes 5 studies in 58 results
Show All >>
Drugs Related to mycophenolate mofetil
-
Cyclosporine (Ciclosporin)
-
Cyclophosphamide (Cytoxan)
-
Azathioprine (Imuran)
-
Tacrolimus (Prograf)
-
Methotrexate (Mexate)
-
Prednisolone (Predate)
-
Immunosuppressive Agents (Immunosuppressants)
-
Adrenal Cortex Hormones (Corticosteroids)
-
Sirolimus (Rapamycin)
-
Methylprednisolone
Show All >>
Therapies Related to mycophenolate mofetil
-
Homologous Transplantation (Allograft)
-
Kidney Transplantation
-
Transplantation (Transplant Recipients)
-
Transplants (Transplant)
-
Hematopoietic Stem Cell Transplantation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.